US Medicare Agency Clarifies View Of Accelerated Approval

 
• By Michael McCaughan

CMS says it has not changed its historical policy towards drugs granted Accelerated Approval. The agency does, however, appear to be suggesting grounds for skepticism towards novel uses of the regulatory pathway.

CMS_accelerated_approval
The Medicare agency says it is standing pat on its approach to accelerated approval. • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images

More from Medicare

More from Government Payers